Last Updated on January 9, 2021 by The Health Master
The US Food and Drug Administration (USFDA) has approved company’s abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg.
This drug is for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy, JB Chemicals and Pharmaceuticals said in a regulatory filing.
JB Chemicals’ product is a generic version of Bayer Healthcare’s Clartin tablets.
“The company expects to commercialise this product in the first quarter of 2021-22 and is expected to improve its US sales,” the drug firm noted.
Go to main website, click here
Subscribe for daily free updates, click here